Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
We have previously shown that high molecular weight (MW > 100 kDa) chitosan nanocapsules are efficient vehicles for improving the oral absorption of salmon calcitonin (sCT). In the present work, our objectives were, first, to investigate the influence of some formulation parameters on the efficacy of chitosan nanocapsules as carriers for the oral administration of sCT and, second, to elucidate the mechanism of interaction of chitosan nanocapsules with intestinal model cell lines.
sCT-loaded chitosan nanocapsules were prepared by the solvent displacement technique. They were characterized for their size, zeta potential, and sCT loading. The ability of chitosan nanocapsules to enhance the oral absorption of sCT was investigated in rats by monitoring the serum calcium levels. Finally, the mechanism of interaction of chitosan nanocapsules with the Caco-2 cell model or in the coculture of Caco-2 with HT29-M6 cells was investigated by confocal fluorescence microscopy.
Chitosan nanocapsules presented a particle size in nanometer range, a positive surface charge, and an efficient encapsulation of sCT. Following oral administration to rats, all formulations of nanocapsules exhibited the ability to reduce calcemia levels; however, the intensity of the response varied depending on the formulation conditions. With regard to the mechanism of interaction of chitosan nanocapsules with cell culture, the xz images evidenced that chitosan nanocapsules interact and remain associated to the apical side of both model cell cultures. In addition, chitosan nanocapsules showed a preferable association to the mucus-secreting cells (HT29-M6).
Chitosan nanocapsules are able to enhance and prolong the intestinal absorption of sCT and this effect could be mainly ascribed to their mucoadhesive character and intimate interaction with the intestinal barrier.
- Lowe, P. L., Temple, C. S. (1994) Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption. J. Pharm. Pharmacol. 46: pp. 547-552
- Yoo, H. S., Park, T. G. (2004) Biodegradable nanoparticles containing protein–fatty acid complexes for oral delivery of salmon calcitonin. J. Pharm. Sci. 93: pp. 488-495
- Tobío, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., Alonso, M. J. (2000) The role of PEG on the stability in digestive fluids and in vivo fate of PEG–PLA nanoparticles following oral administration. Colloids Surf. 18: pp. 315-323
- Behrens, I., Pena, A. I., Alonso, M. J., Kissel, T. (2002) Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm. Res. 19: pp. 1185-1193 CrossRef
- Florence, A. T. (2004) Issues in oral nanoparticle drug carrier uptake and targeting. J. Drug Target. 12: pp. 65-70 CrossRef
- Florence, A. T. (1997) The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14: pp. 259-266 CrossRef
- Jani, P. U., Halbert, G. W., Langridge, J., Florence, A. T. (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42: pp. 821-826
- Desai, M. P., Labhasetwar, V., Amidon, G. L., Levy, R. J. (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 13: pp. 1838-1845 CrossRef
- Jung, T., Kamm, W., Breitenbach, A., Kaiserling, E., Xiao, J. X., Kissel, T. (2000) Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 50: pp. 147-160
- Nakamura, K., Murray, R. J., Joseph, J. I., Peppas, N. A., Morishita, M., Lowman, A. M. (2004) Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J. Control. Release 95: pp. 589-599 CrossRef
- Morishita, M., Goto, T., Peppas, N. A., Joseph, J. I., Torjman, M. C., Munsick, C., Nakamura, K., Yamagata, T., Takayama, K., Lowman, A. M. (2004) Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J. Control. Release 97: pp. 115-124 CrossRef
- Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Vijayaraghavan, K., Montgomery, S., Bassett, M., Morrell, C. (1997) Biologically erodable microspheres as potential oral drug delivery systems. Nature 386: pp. 410-414 CrossRef
- Carino, G. P., Jacob, J. S., Mathiowitz, E. (2000) Nanosphere based oral insulin delivery. J. Control. Release 65: pp. 261-269 CrossRef
- Kawashima, Y., Yamamoto, H., Takeuchi, H., Kuno, Y. (2000) Mucoadhesive dl-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm. Dev. Technol. 5: pp. 77-85 CrossRef
- Prego, C., Torres, D., Alonso, M. J. (2005) The potential of chitosan for the oral administration of peptides. Expert Opin. Drug Deliv. 2: pp. 843-854 CrossRef
- Norris, D. A., Sinko, P. J. (1997) Effect of size, surface charge and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J. Appl. Polym. Sci. 11: pp. 1481-1492
- Sakuma, S., Sudo, R., Suzuki, N., Kikuchi, H., Akashi, M., Hayashi, M. (1999) Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int. J. Pharm. 177: pp. 161-172 CrossRef
- Schipper, N. G. M., Varum, K. M., Stenberg, P., Ocklind, G., Lennerna, H., Artursson, P. (1999) Chitosans as absorption enhancers of poorly absorbable drugs: 3. Influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8: pp. 335-343
- Takeuchi, H., Yamamoto, H., Kawashima, Y. (2001) Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47: pp. 39-54 CrossRef
- Takeuchi, H., Matsui, Y., Yamamoto, H., Kawashima, Y. (2003) Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J. Control. Release 86: pp. 235-242 CrossRef
- Prego, C., García, M., Torres, D., Alonso, M. J. (2005) Transmucosal macromolecular drug delivery. J. Control. Release 101: pp. 151-162 CrossRef
- C. Prego, D. Torres, and M. J. Alonso. Chitosan nanocapsules as oral peptide delivery systems: a study of their efficacy and mechanism of action. 2nd World Congress of the Board of Pharmaceutical Sciences of FIP, Kyoto, 2004.
- Artursson, P. (1991) Cell cultures as models for drug absorption across the intestinal mucosa. Crit. Rev. Ther. Drug Carr. Syst. 8: pp. 305-330
- Janes, K. A., Alonso, M. J. (2003) Depolymerized chitosan nanoparticles for protein delivery: preparation and characterization. J. Appl. Polym. Sci. 88: pp. 2769-2776 CrossRef
- Gamzazade, A. I., Skljar, V. M., Stykova, E. V., Pavlova, S. S. A., Rogozin, S. V. (1985) Investigation for the hydrodynamic properties of chitosan solutions. Acta Polym. 36: pp. 420-424 CrossRef
- Calvo, P., Remuñán-Lopez, C., Vila-Jato, J. L., Alonso, M. J. (1997) Development of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron-emulsion. Colloid Polym. Sci. 275: pp. 46-53 CrossRef
- C. Prego, M. J. Alonso, and D. Torres. Chitosan nanocapsules: new carriers for oral administration of peptides. 5th Spanish Portuguese Conference on Controlled Drug Delivery. Sevilla, 2002.
- Vila, A., Sanchez, A., Janes, K., Behrens, I., Kissel, T., Vila-Jato, J. L., Alonso, M. J. (2004) Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur.J. Pharm. Biopharm. 57: pp. 123-131
- Ma, Z., Lim, L. (2003) Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles. Pharm. Res. 20: pp. 1812-1819 CrossRef
- Garcia-Fuentes, M., Prego, C., Torres, D., Alonso, M. J. (2005) A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly (ethylene glycol) as carriers for oral calcitonin delivery. Eur. J. Pharm. Sci. 25: pp. 133-143
- Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
Volume 23, Issue 3 , pp 549-556
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- oral peptide delivery
- Industry Sectors
- Author Affiliations
- 1. Department of Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela (USC), Campus Sur, 15782, Santiago de Compostela, Spain
- 2. Advancell S.L., Parc Cientific, 08028, Barcelona, Spain